Nanotechnology in adjuvants and vaccine development: what should we know?

被引：4
|
作者：
Assis, Bruna Rodrigues Dias [1 ]
da Silva, Caroline Dohanik [1 ]
Santiago, Marie Gabriele [1 ]
Ferreira, Lucas Antonio Miranda [1 ]
Goulart, Gisele Assis Castro [1 ]
机构：
[1] Univ Fed Minas Gerais, Fac Farma, Dept Prod Farmaceut, BR-31270901 Belo Horizonte, MG, Brazil
来源：
NANOMEDICINE | 2021年 / 16卷 / 29期
关键词：
adjuvants; immunogenicity; nanotechnology; vaccines; NANOPARTICLES;
D O I：
10.2217/nnm-2021-0360
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：2565 / 2568
页数：4
相关论文
共 50 条
  • [11] ADHD IN ADULTS WITH ID: WHAT WE KNOW AND WHAT WE SHOULD KNOW
    Salerno, L.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2015, 59 : 30 - 31
  • [12] Metal sulfide complexing - What we know and what we should know
    Seward, T. M.
    GEOCHIMICA ET COSMOCHIMICA ACTA, 2007, 71 (15) : A919 - A919
  • [13] ALLIANCES IN HEALTH-CARE - WHAT WE KNOW, WHAT WE THINK WE KNOW, AND WHAT WE SHOULD KNOW
    ZUCKERMAN, HS
    KALUZNY, AD
    RICKETTS, TC
    HEALTH CARE MANAGEMENT REVIEW, 1995, 20 (01) : 54 - 64
  • [14] Cultured meat production: what we know, what we don't know and what we should know
    Olenic, Maria
    Thorrez, Lieven
    ITALIAN JOURNAL OF ANIMAL SCIENCE, 2023, 22 (01) : 749 - 753
  • [15] Organizational unlearning as a process: What we know, what we don't know, what we should know
    Klammer, Adrian
    Grisold, Thomas
    Nguyen, Nhien
    Hsu, Shih-wei
    MANAGEMENT REVIEW QUARTERLY, 2024,
  • [16] FROM TINNITUS TO MISOPHONIA: WHAT WE KNOW, WHAT WE DON'T KNOW, AND WHAT WE SHOULD KNOW
    Dobel, Christian
    Keil, Andreas
    PSYCHOPHYSIOLOGY, 2024, 61 : S73 - S73
  • [17] Chronic prostatitis: what we know, what we do not know, and what we should do!
    Lobel, B
    Rodriguez, A
    WORLD JOURNAL OF UROLOGY, 2003, 21 (02) : 57 - 63
  • [18] Chronic prostatitis: what we know, what we do not know, and what we should do!
    B. Lobel
    A. Rodriguez
    World Journal of Urology, 2003, 21 : 57 - 63
  • [19] Doing What we Know we Should: Engaged scholarship and community development
    Muirhead, Bruce
    Woolcock, Geoff
    GATEWAYS-INTERNATIONAL JOURNAL OF COMMUNITY RESEARCH AND ENGAGEMENT, 2008, 1 : 8 - 30
  • [20] Idarucizumab: What Should We Know?
    Cortese, Francesca
    Calculli, Giacinto
    Gesualdo, Michele
    Cecere, Annagrazia
    Zito, Annapaola
    De Vito, Fiorella
    Carbonara, Rossella
    Carbonara, Santa
    Cortese, Anna Maria
    Ciccone, Marco Matteo
    CURRENT DRUG TARGETS, 2018, 19 (01) : 81 - 88
12345